Upgrade to SI Premium - Free Trial

Sarepta Therapeutics (SRPT) PT Lowered to $27 at Leerink Partners

March 1, 2017 7:34 AM
Leerink Partners lowered its price target on Sarepta Therapeutics (NASDAQ: SRPT) to $27.00 (from $32.00) while maintaining a Market Perform ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles